CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2015 - 2026)
CRISPR Therapeutics AG (CRSP) posted Exchange Rate Effect of -$32000.0 for Q1 2026, down 3300.0% sequentially from $1000.0 in Q4 2025, and down 178.05% YoY from $41000.0 in Q1 2025.
CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has reported Exchange Rate Effect for 12 years, with the latest figure at -$32000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 178.05% year-over-year to -$32000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22000.0 (down 29.03% YoY) and the FY2025 annual result came in at $95000.0, up 552.38% from the prior year.
- Exchange Rate Effect retreated to -$32000.0 in Q1 2026 per CRSP's latest filing, from $1000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $115000.0 in Q4 2022 and troughed at -$100000.0 in Q3 2022.
- A 5-year average of $2058.8 and a median of $1000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect sank 1460.0% in 2022, then surged 3900.0% in 2025.
- Over 5 years, Exchange Rate Effect stood at $115000.0 in 2022, then plunged by 46.96% to $61000.0 in 2023, then sank by 242.62% to -$87000.0 in 2024, then jumped by 101.15% to $1000.0 in 2025, then slumped by 3300.0% to -$32000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$32000.0, $1000.0, and -$27000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | -32,000.00 |
| Mar 31, 2026 | -32,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Mar 31, 2024 | -11,000.00 |